The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism

Structure

Volumn 22, Issue 12, 2014, Pages 1744-1753

  Cero, Cheryl ^a   Vostrikov, Vitaly V ^a   Verardi, Raffaello ^a   Severini, Cinzia ^b   Gopinath, Tata ^a   Braun, Patrick D ^a   Sassano, Maria F ^c   Gurney, Allison ^a   Roth, Bryan L ^c   Vulchanova, Lucy ^a   Possenti, Roberta ^b,d   Veglia, Gianluigi ^a   Bartolomucci, Alessandro ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b CNR   (Italy)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT C3A RECEPTOR; COMPLEMENT RECEPTOR; PEPTIDE FRAGMENT; PROTEIN BINDING; TLQP-21 PEPTIDE;

ADIPOCYTE; ANIMAL; CHEMICAL STRUCTURE; CYTOLOGY; FEMALE; METABOLISM; MOUSE; PROTEIN CONFORMATION; RAT; SPLEEN; WISTAR RAT;

ADIPOCYTES; ANIMALS; FEMALE; MICE; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN CONFORMATION; RATS; RATS, WISTAR; RECEPTORS, COMPLEMENT; SPLEEN;

EID: 84914156029     PISSN: 09692126     EISSN: 18784186     Source Type: Journal    
DOI: 10.1016/j.str.2014.10.001     Document Type: Article

References (56)

1. C. Adessi, and C. Soto Converting a peptide into a drug: strategies to improve stability and bioavailability Curr. Med. Chem. 9 2002 963 978
2. E. Aguilar, R. Pineda, F. Gaytán, M.A. Sánchez-Garrido, M. Romero, A. Romero-Ruiz, F. Ruiz-Pino, M. Tena-Sempere, and L. Pinilla Characterization of the reproductive effects of the Vgf-derived peptide TLQP-21 in female rats: in vivo and in vitro studies Neuroendocrinology 98 2013 38 50
3. R.S. Ames, D. Lee, J.J. Foley, A.J. Jurewicz, M.A. Tornetta, W. Bautsch, B. Settmacher, A. Klos, K.F. Erhard, and R.D. Cousins Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models J. Immunol. 166 2001 6341 6348
4. S. Ammoun, T. Holmqvist, R. Shariatmadari, H.B. Oonk, M. Detheux, M. Parmentier, K.E. Akerman, and J.P. Kukkonen Distinct recognition of OX1 and OX2 receptors by orexin peptides J. Pharmacol. Exp. Ther. 305 2003 507 514
5. N.A. Baker, D. Sept, S. Joseph, M.J. Holst, and J.A. McCammon Electrostatics of nanosystems: application to microtubules and the ribosome Proc. Natl. Acad. Sci. USA 98 2001 10037 10041
6. A. Bartolomucci, G. La Corte, R. Possenti, V. Locatelli, A.E. Rigamonti, A. Torsello, E. Bresciani, I. Bulgarelli, R. Rizzi, and F. Pavone TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity Proc. Natl. Acad. Sci. USA 103 2006 14584 14589
7. A. Bartolomucci, R. Possenti, S.K. Mahata, R. Fischer-Colbrie, Y.P. Loh, and S.R. Salton The extended granin family: structure, function, and biomedical implications Endocr. Rev. 32 2011 755 797
8. A.G. Beck-Sickinger, H.A. Wieland, H. Wittneben, K.D. Willim, K. Rudolf, and G. Jung Complete L-alanine scan of neuropeptide Y reveals ligands binding to Y1 and Y2 receptors with distinguished conformations Eur. J. Biochem. 225 1994 947 958
9. V. Cassina, A. Torsello, A. Tempestini, D. Salerno, D. Brogioli, L. Tamiazzo, E. Bresciani, J. Martinez, J.A. Fehrentz, and P. Verdié Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity Biochim. Biophys. Acta 1828 2013 455 460
10. Y.C. Chen, A. Pristerá, M. Ayub, R.S. Swanwick, K. Karu, Y. Hamada, A.S. Rice, and K. Okuse Identification of a receptor for neuropeptide VGF and its role in neuropathic pain J. Biol. Chem. 288 2013 34638 34646
11. L.N. Choy, B.S. Rosen, and B.M. Spiegelman Adipsin and an endogenous pathway of complement from adipose cells J. Biol. Chem. 267 1992 12736 12741
12. F. Engelke, and S. Steuernagel Cross Polarization in Rotating Solids: Spin-1/2 Nuclei. Encyclopedia of Magnetic Resonance 2007 John Wiley & Sons, Ltd Hoboken, NJ
13. C.A. Fairbanks, C.D. Peterson, R.H. Speltz, M.S. Riedl, K.F. Kitto, J.A. Dykstra, P.D. Braun, M. Sadahiro, S.R. Salton, and L. Vulchanova The VGF-derived peptide TLQP-21 contributes to inflammatory and nerve injury-induced hypersensitivity Pain 155 2014 1229 1237
14. S. Fargali, T. Scherer, A.C. Shin, M. Sadahiro, C. Buettner, and S.R. Salton Germline ablation of VGF increases lipolysis in white adipose tissue J. Endocrinol. 215 2012 313 322
15. S. Fargali, A.L. Garcia, M. Sadahiro, C. Jiang, W.G. Janssen, W.J. Lin, V. Cogliani, A. Elste, S. Mortillo, and C. Cero The granin VGF promotes genesis of secretory vesicles, and regulates circulating catecholamine levels and blood pressure FASEB J. 28 2014 2120 2133
16. C.A. Fyfe, K.C. Wong-Moon, Y. Huang, and H. Grondey INEPT experiments in solid-state NMR J. Am. Chem. Soc. 117 1995 10397 10398
17. C. Gaboriaud, J. Juanhuix, A. Gruez, M. Lacroix, C. Darnault, D. Pignol, D. Verger, J.C. Fontecilla-Camps, and G.J. Arlaud The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties J. Biol. Chem. 278 2003 46974 46982
18. A.L. Garcia, S.K. Han, W.G. Janssen, Z.Z. Khaing, T. Ito, M.J. Glucksman, D.L. Benson, and S.R. Salton A prohormone convertase cleavage site within a predicted alpha-helix mediates sorting of the neuronal and endocrine polypeptide VGF into the regulated secretory pathway J. Biol. Chem. 280 2005 41595 41608
19. C.R. Grace, M.H. Perrin, J.P. Cantle, W.W. Vale, J.E. Rivier, and R. Riek Common and divergent structural features of a series of corticotropin releasing factor-related peptides J. Am. Chem. Soc. 129 2007 16102 16114
20. H. Green, and O. Kehinde An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion Cell 5 1975 19 27
21. S. Hahm, T.M. Mizuno, T.J. Wu, J.P. Wisor, C.A. Priest, C.A. Kozak, C.N. Boozer, B. Peng, R.C. McEvoy, and P. Good Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance Neuron 23 1999 537 548
22. S. Hahm, C. Fekete, T.M. Mizuno, J. Windsor, H. Yan, C.N. Boozer, C. Lee, J.K. Elmquist, R.M. Lechan, C.V. Mobbs, and S.R. Salton VGF is required for obesity induced by diet, gold thioglucose treatment, and agouti and is differentially regulated in pro-opiomelanocortin- and neuropeptide Y-containing arcuate neurons in response to fasting J. Neurosci. 22 2002 6929 6938
23. S. Hannedouche, V. Beck, J. Leighton-Davies, M. Beibel, G. Roma, E.J. Oakeley, V. Lannoy, J. Bernard, J. Hamon, and S. Barbieri Identification of the C3a receptor (C3AR1) as the target of the VGF-derived peptide TLQP-21 in rodent cells J. Biol. Chem. 288 2013 27434 27443
24. K. Hollenstein, C. de Graaf, A. Bortolato, M.W. Wang, F.H. Marshall, and R.C. Stevens Insights into the structure of class B GPCRs Trends Pharmacol. Sci. 35 2014 12 22
25. T.E. Hugli, and B.W. Erickson Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin Proc. Natl. Acad. Sci. USA 74 1977 1826 1830
26. P.H. Jethwa, A. Warner, K.N. Nilaweera, J.M. Brameld, J.W. Keyte, W.G. Carter, N. Bolton, M. Bruggraber, P.J. Morgan, P. Barrett, and F.J. Ebling VGF-derived peptide, TLQP-21, regulates food intake and body weight in Siberian hamsters Endocrinology 148 2007 4044 4055
27. S.S. Karnik, C. Gogonea, S. Patil, Y. Saad, and T. Takezako Activation of G-protein-coupled receptors: a common molecular mechanism Trends Endocrinol. Metab. 14 2003 431 437
28. A. Klos, E. Wende, K.J. Wareham, and P.N. Monk International Union of Pharmacology. LXXXVII. Complement peptide C5a, C4a, and C3a receptors Pharmacol. Rev. 65 2013 500 543
29. W.H. Kwan, W. van der Touw, E. Paz-Artal, M.O. Li, and P.S. Heeger Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells J. Exp. Med. 210 2013 257 268
30. J. Lim, A. Iyer, J.Y. Suen, V. Seow, R.C. Reid, L. Brown, and D.P. Fairlie C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling FASEB J. 27 2013 822 831
31. H. Lin, M.F. Sassano, B.L. Roth, and B.K. Shoichet A pharmacological organization of G protein-coupled receptors Nat. Methods 10 2013 140 146
32. J.C. Lo, S. Ljubicic, B. Leibiger, M. Kern, I.B. Leibiger, T. Moede, M.E. Kelly, D. Chatterjee Bhowmick, I. Murano, and P. Cohen Adipsin is an adipokine that improves β cell function in diabetes Cell 158 2014 41 53
33. Y. Mamane, C. Chung Chan, G. Lavallee, N. Morin, L.J. Xu, J. Huang, R. Gordon, W. Thomas, J. Lamb, and E.E. Schadt The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation Diabetes 58 2009 2006 2017
34. K.L. Morrison, and G.A. Weiss Combinatorial alanine-scanning Curr. Opin. Chem. Biol. 5 2001 302 307
35. E.N. Murage, J.C. Schroeder, M. Beinborn, and J.M. Ahn Search for α-helical propensity in the receptor-bound conformation of glucagon-like peptide-1 Bioorg. Med. Chem. 16 2008 10106 10112
36. S. Neelamkavil, B. Arison, E. Birzin, J.J. Feng, K.H. Chen, A. Lin, F.C. Cheng, L. Taylor, E.R. Thornton, A.B. Smith 3rd, and R. Hirschmann Replacement of Phe6, Phe7, and Phe11 of D-Trp8-somatostatin-14 with L-pyrazinylalanine. Predicted and observed effects on binding affinities at hSST2 and hSST4. An unexpected effect of the chirality of Trp8 on NMR spectra in methanol J. Med. Chem. 48 2005 4025 4030
37. D.G. Nettesheim, R.P. Edalji, K.W. Mollison, J. Greer, and E.R. Zuiderweg Secondary structure of complement component C3a anaphylatoxin in solution as determined by NMR spectroscopy: differences between crystal and solution conformations Proc. Natl. Acad. Sci. USA 85 1988 5036 5040
38. K. Pal, K. Melcher, and H.E. Xu Structure and mechanism for recognition of peptide hormones by Class B G-protein-coupled receptors Acta Pharmacol. Sin. 33 2012 300 311
39. C. Parthier, S. Reedtz-Runge, R. Rudolph, and M.T. Stubbs Passing the baton in class B GPCRs: peptide hormone activation via helix induction? Trends Biochem. Sci. 34 2009 303 310
40. M. Pellecchia, I. Bertini, D. Cowburn, C. Dalvit, E. Giralt, W. Jahnke, T.L. James, S.W. Homans, H. Kessler, and C. Luchinat Perspectives on NMR in drug discovery: a technique comes of age Nat. Rev. Drug Discov. 7 2008 738 745
41. R. Possenti, G. Muccioli, P. Petrocchi, C. Cero, A. Cabassi, L. Vulchanova, M.S. Riedl, M. Manieri, A. Frontini, and A. Giordano Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21 Biochem. J. 441 2012 511 522
42. M. Razzoli, E. Bo, T. Pascucci, F. Pavone, F.R. D'Amato, C. Cero, V. Sanghez, H. Dadomo, P. Palanza, and S. Parmigiani Implication of the VGF-derived peptide TLQP-21 in mouse acute and chronic stress responses Behav. Brain Res. 229 2012 333 339
43. R.C. Reid, M.K. Yau, R. Singh, J.K. Hamidon, A.N. Reed, P. Chu, J.Y. Suen, M.J. Stoermer, J.S. Blakeney, and J. Lim Downsizing a human inflammatory protein to a small molecule with equal potency and functionality Nat. Commun. 4 2013 2802
44. R. Rizzi, A. Bartolomucci, A. Moles, F. D'Amato, P. Sacerdote, A. Levi, G. La Corte, M.T. Ciotti, R. Possenti, and F. Pavone The VGF-derived peptide TLQP-21: a new modulatory peptide for inflammatory pain Neurosci. Lett. 441 2008 129 133
45. A. Roglic, E.R. Prossnitz, S.L. Cavanagh, Z. Pan, A. Zou, and R.D. Ye cDNA cloning of a novel G protein-coupled receptor with a large extracellular loop structure Biochim. Biophys. Acta 1305 1996 39 43
46. C. Roy, S. Paglialunga, A. Fisette, P. Schrauwen, E. Moonen-Kornips, J. St-Onge, M.K. Hesselink, D. Richard, D.R. Joanisse, and K. Cianflone Shift in metabolic fuel in acylation-stimulating protein-deficient mice following a high-fat diet Am. J. Physiol. Endocrinol. Metab. 294 2008 E1051 E1059
47. S. Schwarzinger, G.J. Kroon, T.R. Foss, P.E. Wright, and H.J. Dyson Random coil chemical shifts in acidic 8 M urea: implementation of random coil shift data in NMRView J. Biomol. NMR 18 2000 43 48
48. C.D. Schwieters, J.J. Kuszewski, N. Tjandra, and G.M. Clore The Xplor-NIH NMR molecular structure determination package J. Magn. Reson. 160 2003 65 73
49. C. Severini, G. La Corte, G. Improta, M. Broccardo, S. Agostini, C. Petrella, V. Sibilia, F. Pagani, F. Guidobono, and I. Bulgarelli In vitro and in vivo pharmacological role of TLQP-21, a VGF-derived peptide, in the regulation of rat gastric motor functions Br. J. Pharmacol. 157 2009 984 993
50. B.K. Shoichet, and B.K. Kobilka Structure-based drug screening for G-protein-coupled receptors Trends Pharmacol. Sci. 33 2012 268 272
51. S.B. Stephens, J.C. Schisler, H.E. Hohmeier, J. An, A.Y. Sun, G.S. Pitt, and C.B. Newgard A VGF-derived peptide attenuates development of type 2 diabetes via enhancement of islet β-cell survival and function Cell Metab. 16 2012 33 43
52. M. Takahashi, S. Moriguchi, M. Ikeno, S. Kono, K. Ohata, H. Usui, K. Kurahashi, R. Sasaki, and M. Yoshikawa Studies on the ileum-contracting mechanisms and identification as a complement C3a receptor agonist of oryzatensin, a bioactive peptide derived from rice albumin Peptides 17 1996 5 12
53. M. Takahashi, S. Moriguchi, H. Suganuma, A. Shiota, F. Tani, H. Usui, K. Kurahashi, R. Sasaki, and M. Yoshikawa Identification of casoxin C, an ileum-contracting peptide derived from bovine kappa-casein, as an agonist for C3a receptors Peptides 18 1997 329 336
54. W. Vale, J. Spiess, C. Rivier, and J. Rivier Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin Science 213 1981 1394 1397
55. G. Veglia Comprehensive Biophysics. Biophysical Techniques for Structural Characterization of Macromolecules Volume 1 2012 Elsevier Bridgewater, NJ 182 198
56. E. Watson, S. Hahm, T.M. Mizuno, J. Windsor, C. Montgomery, P.E. Scherer, C.V. Mobbs, and S.R. Salton VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity Endocrinology 146 2005 5151 5163